For an innovative bunch, medical device venture capitalists have trouble reinventing themselves. If current conditions continue, they'll need to, and BioStar Ventures could be a firm to emulate, especially if new models require VCs and their funds to be smaller, faster, and better connected.
BioStar Could Light Path For Device Investors
BioStar Ventures, founded by physicians who are leaders in the interventional cardiology field, is demonstrating how medical device investors might benefit with close ties to clinical and corporate worlds.
More from Archive
More from Scrip
• By
Attorneys Andrew Goodman and Alan Minsk, as well as Naya CEO Daniel Teper, discussed the ramifications of US FDA staff cuts on M&A activity with Scrip senior writer Joseph Haas.
• By
The not-for-profit’s senior vice president Martin Ridderstråle explains how it is expanding grants for basic research to improve "human and planetary" health.
• By
As the PDUFA date for the UK major’s IL-5 inhibitor draws close.